High-throughput (HT) sequencing, microarray screening and protein expression profiling technologies drive discovery efforts in today's genomics and proteomics laboratories. These tools allow ...

The field of bioinformatics has seen significant advancements in recent years, particularly in the application of artificial intelligence (AI) for the analysis and interpretation of large-scale data ...

Bioinformatics is an interdisciplinary field that combines biology, computer science, mathematics, and statistics to analyze and interpret biological data. It involves the development and application ...

The Bioinformatics and Biostatistics Core is a collaborative center that provides investigators with bioinformatics expertise to analyze large molecular datasets and develop novel algorithms. We have ...

Refined Tools for Real-Time Single Particle Tracing and Dissection of Signaling Pathways Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter ...

In response to increased economic pressures, research-based pharmaceutical companies are attempting to streamline and accelerate their drug discovery and development processes. With the advent of ...

The Saint Louis University Genomics and Bioinformatics Core Facility provides state-of-the-art single-cell genomics and integrative bioinformatics services to both internal and external researchers.

Proteomics and genomics share the common goal of characterizing biological systems, yet they differ fundamentally in their molecular targets, analytical challenges and interpretive value. Genomics ...

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

I am a computational biologist with comprehensive expertise in bioinformatics, genomics, and structural biology. Serving as a Principal Investigator (PI) or co-PI for several federally funded research ...

ROCKVILLE, Md.--(BUSINESS WIRE)--After finalizing partnerships with 10x Genomics and Olink Proteomics in 2021, Psomagen, Inc., is beginning 2022 by bringing end-to-end multiomics solutions to the drug ...